959O Gavocabtagene autoleucel (gavo-cel, TC-210) dose escalation in refractory mesothelin-expressing solid tumors

Autor: Hong, D.S., SciMentum, S.L., Tanyi, J., MacMullen, L., Jalbert, L., Muzithras, V.P., Zikaras, K., Cao, L., O’Cearbhaill, R.E., Quintás-Cardama, A., Hassan, R.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S830-S830
Databáze: ScienceDirect